Preclinical toxicologic evaluation of nadolol, a new beta-adrenergic antagonist.
D000319:Adrenergic beta-Antagonists / Q000633:toxicity*; D000818:Animals; D001835:Body Weight / Q000187:drug effects; D002273:Carcinogens; D006224:Cricetinae; D004285:Dogs; D005260:Female; D005951:Glucose Tolerance Test; D000882:Haplorhini; D008253:Macaca mulatta; D008297:Male; D008647:Mesocricetus; D051379:Mice; D011247:Pregnancy; D011412:Propanolamines / Q000633:toxicity*; D011817:Rabbits; D051381:Rats; D012098:Reproduction / Q000187:drug effects; D013045:Species Specificity; D013723:Teratogens; D013997:Time Factors
D000319:Adrenergic beta-Antagonists; D002273:Carcinogens; D011412:Propanolamines; D013723:Teratogens